GLAXOSMITH - Glaxo Smithkline Consumer
Manufacturing, Marketing and Distribution of Pharmaceutical, Oral Care and Nutritional Products
NOTE: Shares of Glaxo Smithkline Consumer have been delisted from the Nigerian Stock Exchange (NGX) since close of trading on Friday, February 2, 2024. Glaxo Smithkline Consumer was traded on the NGX under the ticker symbol “GLAXOSMITH”. The International Securities Identification Number (ISIN) of NGX:GLAXOSMITH was NGGLAXOSMTH8. Glaxo Smithkline Consumer was the 66th most valuable stock on the NGX with a market capitalization of NGN 20.3 billion, which made about 0.036% of the Nigerian Stock Exchange equity market at the time of delisting.
Last Trading Results | |
---|---|
Opening Price | |
Day’s Low Price | |
Day’s High Price | |
Traded Volume | 0 |
Number of Deals | 0 |
Gross Turnover | 0.00 |
Growth & Valuation | |
---|---|
Earnings Per Share | |
Price/Earning Ratio | |
Dividend Per Share | |
Dividend Yield | |
Shares Outstanding | 1.2B |
Market Capitalization | 20.3B |
GLAXOSMITH Stock Market Performance
1WK | 4WK | 3MO |
---|---|---|
+37.1% |
6MO | 1YR | YTD |
---|---|---|
+91% | +162% |
The current share price of Glaxo Smithkline Consumer (GLAXOSMITH) is NGN 17.00. GLAXOSMITH closed its last trading day (Friday, January 19, 2024) at 17.00 NGN per share on the Nigerian Stock Exchange (NGX), recording a 1.2% gain over its previous closing price of 16.80 NGN.
Glaxo Smithkline Consumer is the 78th most traded stock on the Nigerian Stock Exchange over the past three months (Nov 3, 2023 - Feb 2, 2024). GLAXOSMITH has traded a total volume of 51.9 million shares—in 1,710 deals—valued at NGN 855 million over the period, with an average of 823,621 traded shares per session. A volume high of 12.2 million was achieved on November 30th for the same period. The table below details the last 10 trading days of activity of Glaxo Smithkline Consumer on the Nigerian Stock Exchange.
Date | Volume | Close | Change | Change% |
---|---|---|---|---|
2024-01-19 | 364,806 | 17.00 | +0.20 | +1.19% |
2024-01-18 | 196,853 | 16.80 | ||
2024-01-17 | 187,641 | 16.80 | ||
2024-01-16 | 151,863 | 16.80 | ||
2024-01-15 | 214,902 | 16.80 | ||
2024-01-12 | 185,919 | 16.80 | ||
2024-01-11 | 23,477 | 16.80 | ||
2024-01-10 | 1,441,441 | 16.80 | -0.20 | -1.18% |
2024-01-09 | 1,605,447 | 17.00 | ||
2024-01-08 | 830,006 | 17.00 |
Profile of Glaxo Smithkline Consumer
Glaxo Smithkline Consumer operates in the Health Care sector.
Factsheet of Glaxo Smithkline Consumer
- Sector
- Health Care
- Industry
- —
- Address
- 1, Industrial Avenue, Ilupeju Lagos
- Telephone
- 2711000
- Website
- www.gsk.com/ng
GLAXOSMITH Industrial Market Competitors
Glaxo Smithkline Consumer, issuers of the GLAXOSMITH stock on the Nigerian Stock Exchange, have seven market competitors who are also engaged in the Health Care sector. The table below presents an overview of their market standing.
Code | Name | M. Cap. | Close | YTD |
---|---|---|---|---|
MORISON | Morison Industries | 4.4B | 4.45 | +58.9% |
MAYBAKER | May & Baker Nigeria | 12.5B | 7.25 | +38.1% |
NEIMETH | Neimeth International Pharma | 8.33B | 1.95 | +0.52% |
EKOCORP | Ekocorp Plc | 2.89B | 5.80 | +0.17% |
PHARMDEKO | Pharma-Deko Plc | 397M | 1.83 | |
FIDSON | Fidson Healthcare | 35.5B | 15.45 | -11.7% |
MECURE | MeCure Industries | 33.8B | 8.45 | -29.6% |